Thermo Fisher launches LDT to support tailored immunosuppressant dosing
Thermo Fisher Scientific has launched a new laboratory-developed test (LDT) to guide clinicians in their dosing of tacrolimus, a commonly…
27 Feb 2026
Ottobock invests $5m in Blue Arbor for prosthetic control advancement
Blue Arbor Technologies and German prosthetics company Ottobock have partnered to advance clinical and commercial activities for the former’s prosthetic control system for people with limb loss. Under the strategic…
27 Feb 2026
Academia Sinica and NTU Hospital develop AI model for pancreatic cancer
Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects molecular…
27 Feb 2026
ENDRA reports favourable data from Taeus Liver device study in MASLD
ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in metabolic dysfunction-associated steatotic liver disease (MASLD). The study focused on the…
26 Feb 2026
GE HealthCare launches general imaging ultrasound systems
GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite workflows. The new systems introduce advanced imaging technologies, AI-powered automation, and an expanded…
26 Feb 2026
Quantum acquires NeuWave Medical to enhance tumour ablation treatments
Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer mortality. The move brings together two medical device businesses with…
25 Feb 2026
TECLens begins first-in-human trial for qCXL vision correction technology
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial patient. The qCXL platform aims to…